H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Census population 873,965. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed San Francisco clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a San Francisco storefront.
Sports Injury Biologic Treatments in San Francisco, CA for clinics & physicians. Biologic treatments for s… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. Obesity 17.5%; arthritis 16.7%. Those three PLACES crude rates (plus Census 873,965) are the local facts on this page. Everything else is the national sports injury biologics catalog and JE paperwork.
National Sports Injury Biologic Treatments notes (how the product actually works)California shares JE with HI, NV. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 9.7% of adults in San Francisco have diagnosed diabetes — 2.3 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the sports injury biologics account.
CDC PLACES (2023, crude prevalence) estimates 9.7% of adults — 2.3 points below the U.S. 12% figure. Obesity is 17.5%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a San Francisco trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including California.
California is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.7% diabetes and 16.7% arthritis for San Francisco — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in San Francisco, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for San Francisco is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for San Francisco — 2.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in San Francisco. Useful for joint-program math; still needs a diagnosis and privileging.
No San Francisco storefront. Joe Bradley is an active practice owner. sports injury biologics stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.